Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Association between Eight Functional Polymorphisms and Haplotypes in the Cholesterol Ester Transfer Protein (CETP) Gene and Dyslipidemia in National Minority Adults in the Far West Region of China.

Guo S, Hu Y, Ding Y, Liu J, Zhang M, Ma R, Guo H, Wang K, He J, Yan Y, Rui D, Sun F, Mu L, Niu Q, Zhang J, Li S.

Int J Environ Res Public Health. 2015 Dec 16;12(12):15979-92. doi: 10.3390/ijerph121215036.

2.

Lipid levels in HIV-positive men receiving anti-retroviral therapy are not associated with copy number variation of reverse cholesterol transport pathway genes.

Marino RB, Kingsley LA, Hussain SK, Bream JH, Penogonda S, Duggal P, Martinson JJ.

BMC Res Notes. 2015 Nov 21;8(1):697. doi: 10.1186/s13104-015-1665-z.

3.

New Approaches in Detection and Treatment of Familial Hypercholesterolemia.

Hartgers ML, Ray KK, Hovingh GK.

Curr Cardiol Rep. 2015 Dec;17(12):109. doi: 10.1007/s11886-015-0665-x.

4.

Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.

Le Bloc'h J, Leray V, Nazih H, Gauthier O, Serisier S, Magot T, Krempf M, Nguyen P, Ouguerram K.

PLoS One. 2015 Sep 14;10(9):e0136934. doi: 10.1371/journal.pone.0136934. eCollection 2015.

5.

Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism.

Salminen LE, Schofield PR, Pierce KD, Luo X, Zhao Y, Laidlaw DH, Cabeen RP, Conturo TE, Lane EM, Heaps JM, Bolzenius JD, Baker LM, Cooley SA, Scott S, Cagle LM, Paul RH.

J Neural Transm (Vienna). 2015 Nov;122(11):1581-92. doi: 10.1007/s00702-015-1434-0. Epub 2015 Aug 8.

PMID:
26253899
6.

Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP.

Yokoyama S, Okumura-Noji K, Lu R.

J Biomed Res. 2015 May;29(3):176-88. doi: 10.7555/JBR.29.20150005. Epub 2015 Apr 15. Review.

7.

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

Millar JS, Reyes-Soffer G, Jumes P, Dunbar RL, deGoma EM, Baer AL, Karmally W, Donovan DS, Rafeek H, Pollan L, Tohyama J, Johnson-Levonas AO, Wagner JA, Holleran S, Obunike J, Liu Y, Ramakrishnan R, Lassman ME, Gutstein DE, Ginsberg HN, Rader DJ.

J Clin Invest. 2015 Jun;125(6):2510-22. doi: 10.1172/JCI80025. Epub 2015 May 11.

8.

Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors.

Yokoyama S.

Nutrients. 2015 Apr 2;7(4):2359-81. doi: 10.3390/nu7042359. Review.

9.
10.

Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Morton RE, Izem L.

J Lipid Res. 2015 Mar;56(3):612-9. doi: 10.1194/jlr.M056333. Epub 2015 Jan 23.

PMID:
25616437
11.

CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.

Qi Q, Durst R, Schwarzfuchs D, Leitersdorf E, Shpitzen S, Li Y, Wu H, Champagne CM, Hu FB, Stampfer MJ, Bray GA, Sacks FM, Shai I, Qi L.

J Lipid Res. 2015 Mar;56(3):713-21. doi: 10.1194/jlr.P055715. Epub 2014 Dec 29.

PMID:
25548261
12.

Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction.

Cao M, Zhou ZW, Fang BJ, Zhao CG, Zhou D.

Medicine (Baltimore). 2014 Nov;93(26):e160. doi: 10.1097/MD.0000000000000160. Review.

13.
15.

Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.

Hishida A, Wakai K, Naito M, Suma S, Sasakabe T, Hamajima N, Hosono S, Horita M, Turin TC, Suzuki S, Kairupan TS, Mikami H, Ohnaka K, Watanabe I, Uemura H, Kubo M, Tanaka H; J-MICC Study Group.

Lipids Health Dis. 2014 Oct 14;13:162. doi: 10.1186/1476-511X-13-162.

16.

CETP inhibitors and cardiovascular disease: Time to think again.

Miller NE.

F1000Res. 2014 Jun 10;3:124. doi: 10.12688/f1000research.4396.1. eCollection 2014.

17.

Evolving targets for lipid-modifying therapy.

Do RQ, Nicholls SJ, Schwartz GG.

EMBO Mol Med. 2014 Aug 29;6(10):1215-30. doi: 10.15252/emmm.201404000. Review.

18.

Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study.

Nakamura H, Mizuno K; MEGA Study Group.

Lipids Health Dis. 2014 Aug 18;13:133. doi: 10.1186/1476-511X-13-133.

19.

Identification of genes contributing to cardiovascular disease in overweight and obese individuals from West Virginia.

Dementieva Y, Green TL, Primerano DA, Wei L, Denvir J, Wehner P, Dodson S, Flood MR, Pollock BA, Huff M, Hill C, Kreisberg R, Francis A, Morrison K, Blackwood H, Davis M, Lee HM, Warren S; Appalachian Cardiovascular Research Network.

W V Med J. 2012 Jan-Feb;108(1):23-6, 28-30.

20.

Treatment of dyslipidemia.

Tonkin A, Byrnes A.

F1000Prime Rep. 2014 Mar 3;6:17. doi: 10.12703/P6-17. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk